SE415255B - Forfarande for framstellning av furoylettiksyra - derivat med hypolipidemisk verkan - Google Patents

Forfarande for framstellning av furoylettiksyra - derivat med hypolipidemisk verkan

Info

Publication number
SE415255B
SE415255B SE7404353A SE7404353A SE415255B SE 415255 B SE415255 B SE 415255B SE 7404353 A SE7404353 A SE 7404353A SE 7404353 A SE7404353 A SE 7404353A SE 415255 B SE415255 B SE 415255B
Authority
SE
Sweden
Prior art keywords
furoyletic
derivatives
procedure
preparation
acid
Prior art date
Application number
SE7404353A
Other languages
English (en)
Swedish (sv)
Inventor
R A Parker
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE415255B publication Critical patent/SE415255B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
SE7404353A 1973-04-02 1974-04-01 Forfarande for framstellning av furoylettiksyra - derivat med hypolipidemisk verkan SE415255B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/347,232 US4000164A (en) 1973-04-02 1973-04-02 Hypolipidemic agents

Publications (1)

Publication Number Publication Date
SE415255B true SE415255B (sv) 1980-09-22

Family

ID=23362868

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7404353A SE415255B (sv) 1973-04-02 1974-04-01 Forfarande for framstellning av furoylettiksyra - derivat med hypolipidemisk verkan

Country Status (13)

Country Link
US (1) US4000164A (US20030204162A1-20031030-M00001.png)
JP (1) JPS5844663B2 (US20030204162A1-20031030-M00001.png)
AU (1) AU473144B2 (US20030204162A1-20031030-M00001.png)
BE (1) BE813041A (US20030204162A1-20031030-M00001.png)
CA (1) CA1031355A (US20030204162A1-20031030-M00001.png)
CH (1) CH603615A5 (US20030204162A1-20031030-M00001.png)
DE (1) DE2414252A1 (US20030204162A1-20031030-M00001.png)
FR (1) FR2223031B1 (US20030204162A1-20031030-M00001.png)
GB (1) GB1417103A (US20030204162A1-20031030-M00001.png)
NL (1) NL7404218A (US20030204162A1-20031030-M00001.png)
PH (1) PH24978A (US20030204162A1-20031030-M00001.png)
SE (1) SE415255B (US20030204162A1-20031030-M00001.png)
ZA (1) ZA741421B (US20030204162A1-20031030-M00001.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032647A (en) * 1975-06-16 1977-06-28 Richardson-Merrell Inc. Substituted thenoylacetic acid and esters
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB1540917A (en) * 1976-08-06 1979-02-21 Wassermann Spa A Furan derivatives for use as pharmaceutical products particularly for the treatment of rheumatic illnesses and a method for their preparation
CA1104574A (en) * 1976-12-20 1981-07-07 Roger A. Parker Antirhinovirus agents
US4169202A (en) * 1978-06-05 1979-09-25 American Home Products Corporation Process for preparing 4,5-dihydro-4-oxofuran-2-carboxylic acid derivatives
US4980371A (en) * 1988-12-21 1990-12-25 Merrell Dow Pharmaceuticals Antiretroviral furan ketones
US4977185A (en) * 1988-12-21 1990-12-11 Merrell Dow Pharmaceuticals Antiretroviral aryloxy substituted furan ketones
US5665874A (en) * 1989-01-17 1997-09-09 John Hopkins University Cancer related antigen
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2834789A (en) * 1955-02-15 1958-05-13 Sadolin & Holmblad As Process of preparing lower lakyl 2, 3, 6-trihydroxybenzoate, and intermediates therefor

Also Published As

Publication number Publication date
NL7404218A (US20030204162A1-20031030-M00001.png) 1974-10-04
AU6649674A (en) 1975-09-11
JPS49127964A (US20030204162A1-20031030-M00001.png) 1974-12-07
PH24978A (en) 1990-12-26
DE2414252A1 (de) 1974-10-17
ZA741421B (en) 1975-01-29
FR2223031B1 (US20030204162A1-20031030-M00001.png) 1977-01-21
CA1031355A (en) 1978-05-16
FR2223031A1 (US20030204162A1-20031030-M00001.png) 1974-10-25
DE2414252C2 (US20030204162A1-20031030-M00001.png) 1988-02-18
JPS5844663B2 (ja) 1983-10-04
US4000164A (en) 1976-12-28
CH603615A5 (US20030204162A1-20031030-M00001.png) 1978-08-31
BE813041A (fr) 1974-07-15
AU473144B2 (en) 1976-06-17
GB1417103A (en) 1975-12-10

Similar Documents

Publication Publication Date Title
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
SE419605B (sv) Forfarande for framstellning av undertrycksformad gjutform
SE406467B (sv) Nytt forfarande for framstellning av bensotiazinforeningar med antiinflammatorisk verkan
NO142196C (no) Fremgangsmaate for fremstilling av avfarvede kaldtvannsopploeselige tegarvestoffer
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
SE7513085L (sv) Forfarande for framstellning av etrar
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
SE415255B (sv) Forfarande for framstellning av furoylettiksyra - derivat med hypolipidemisk verkan
FI55846B (fi) Foerfarande foer framstaellning av 8-azapurin-5-onderivat med terapeutisk anvaendning
NO142628C (no) Fremgangsmaate for fremstilling av polylaktoner
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
RO70474A (ro) PROCEDEU PENTRU PREPARAREA PARAXILENULёI
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE417721B (sv) Forfarande for framstellning av fenol-aldehydskumplast
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
TR17584A (tr) Herbisid triazinlerinin hazirlanmasina mahsus usul
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
AR206610A1 (es) Procedimiento de preparacion de 2-metoxi-5-sulfonil(sustituidos)-benzamidas-(-sustituidas
SE409716B (sv) Analogiforfarande for framstellning av 11beta-alkyl-deltaŸ4-estrener
SE426582B (sv) Forfarande for framstellning av foreningar med kolesterolsenkande effekt
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE409994B (sv) Forfarande for framstellning av amidinokarbamider

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7404353-0

Effective date: 19940510

Format of ref document f/p: F